Reckitt Benckiser stock heads into the open after a 2.3 percent drop

At the close on September 16, 2026, Reckitt Benckiser stock finished at 566.80 pence on the London Stock Exchange, down 2.33 percent with a session low near the close, while the FTSE 100 added 0.28 percent. Today, investors watch fresh plans to expand U.S. operations.

Reckitt Benckiser stock closed at 566.80 pence on the London Stock Exchange on September 16, 2026, down 2.33% from the prior session. The move left the shares underperforming the FTSE 100, which gained 0.28% on the same day.

September 16, 2026 in numbers

Reckitt Benckiser Group plc (ISIN GB00B24CGK77, London: RKT) ended the September 16, 2026 session at 566.80 pence after trading between an intraday high above 5,056 pence and a low near the closing level, according to London quote data. Volume on the day reflected active trading compared with recent sessions as the stock declined 2.33%, while the FTSE 100 index closed up 0.28% at 10,688.47 points per Borsa Italiana data for the London market. As reported by PR Newswire on September 16, 2026, the company announced plans for up to USD 600 million of multi-year investment in its United States operations to accelerate innovation, expand access to healthcare products and strengthen supply resilience, a strategic update that framed the session. A European market wrap from Finversia noted that Reckitt Benckiser shares slipped around 0.2% as broader European equities advanced, highlighting the stock lagging the regional risk-on move ahead of the Federal Reserve decision.

Strategic plans and data today

Today, the market focus for Reckitt Benckiser centers on follow-up to the September 16, 2026 announcement that the company will invest up to USD 600 million over multiple years to upgrade U.S.-based production and innovation capabilities, as detailed by PR Newswire. Coverage by Wall Street Journal and AskTraders emphasized that approximately USD 400 million of this total is earmarked for the next four years, building on earlier commitments, which may keep attention on the company ahead of the London and U.S. sessions. With the FTSE 100 having closed higher on September 16, 2026 and global markets attuned to forthcoming Federal Reserve communications, the stock enters today’s trading against a backdrop of sector rotation described in a health care roundup by MarketWatch, which highlighted ongoing investor interest in rate-sensitive and defensive names.